Clinical manifestations and diagnosis of lyme borreliosis

Current Problems in Dermatology

Volumn 37, Issue , 2009, Pages 51-110

  Strle, Franc ^a   Stanek, Gerold ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ANTIINFECTIVE AGENT;

ACROCYANOSIS; ACRODERMATITIS CHRONICA ATROPHICANS; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ARTHRITIS; B CELL LYMPHOMA; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BORRELIA AFZELII; BORRELIA BURGDORFERI; BORRELIA GARINII; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CHRONIC VEIN INSUFFICIENCY; CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DRUG TREATMENT FAILURE; ECZEMA; EOSINOPHILIC FASCIITIS; ERYTHEMA CHRONICUM MIGRANS; EYE DISEASE; FACIAL NERVE PARALYSIS; HEART MUSCLE CONDUCTION DISTURBANCE; HEMIFACIAL ATROPHY; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IXODES RICINUS; LABORATORY DIAGNOSIS; LABORATORY TEST; LICHEN SCLEROSUS ET ATROPHICUS; LIVEDO RETICULARIS; LYME DISEASE; LYMPHEDEMA; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOMA; MORBIDITY; MORPHEA; MYCOSIS; MYOCARDITIS; MYOSITIS; NEURITIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; ORGAN TRANSPLANTATION; PATHOGENESIS; PERICARDITIS; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; SEROPREVALENCE; SKIN BIOPSY; SKIN CULTURE; SKIN DEFECT; SKIN LYMPHOMA; SKIN MANIFESTATION; STRAIN DIFFERENCE; SUPERFICIAL THROMBOPHLEBITIS; TICK BITE; TREATMENT DURATION; TREATMENT OUTCOME; WESTERN BLOTTING; ANIMAL; ARTICLE; BACTERIAL SKIN DISEASE; MICROBIOLOGY; PATHOLOGY; SKIN;

ANIMALS; ANTI-BACTERIAL AGENTS; ARTHRITIS; EYE DISEASES; HUMANS; LYME DISEASE; MYOCARDITIS; SKIN; SKIN DISEASES, BACTERIAL;

EID: 67649510116     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000213070     Document Type: Review

References (274)

1. Nadelman RB, Wormser GP: Lyme borreliosis. La ncet 1998;352:557-565.
2. Strle F: Principles of the diagnosis and antibiotic treatment of Lyme borreliosis. Wien Klin Wochenschr 1999;111:911-915.
3. Stanek G, Strle F: Lyme borreliosis. Lancet 2003;362:1639-1647.
4. Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA: Erythema chronicum migrans and Lyme arthritis: the enlarging clinical spect rum. Ann Intern Med 1977;86:685-698.
5. Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM: Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17.
6. The Free Dictionary: Medical dictionary. www. thefreedictionary.com.
7. Steere AC, Sikand VK, Schoen RT, Nowakowski J: Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis 2003;37:528-532.
8. Gustafson R, Svenungsson B, Gardulf A, Stiernstedt G, Forsgren M: Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population. Scand J Infect Dis 1990;22:297-306.
9. Fahrer H, van der Linden SM, Sauvain MJ, Gern L, Zhioua E, Aeschlimann A: The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J Infect Dis 1991;163:305-310.
10. Zhioua E, Gern L, Aeschlimann A, Sauvain MJ, van der Linden S, Fahrer H: Longitudina l study of Lyme borreliosis in a high risk population in Switzerland. Parasite 1998;5:383-386.
11. Anonymous: Case definitions for infectious conditions under public health surveillance: Lyme disease (revisited 9/96). MMWR Morb Mortal Wkly Rep 1997;46(suppl RR-10):20-21.
12. Stanek G, O'Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, Guy E, Gray J: European Union Concerted Action on Risk Assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996;108:741-747.
13. Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoersdorff A, Blanco JR, Caruso G, Cinco M, Fourni-er PE, Francavilla E, Jensenius M, Kazar J, Laferl H, Lakos A, Lotric Furlan S, Maurin M, Oteo JA, Parola P, Perez-Eid C, Peter O, Postic D, Raoult D, Tellez A, Tselentis Y, Wilske B: Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 2004;10:1108-1132.
14. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler S, Nadelman R: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089-1134.
15. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, Maraspin V, Aguero-Rosenfeld ME, Varde S, Lotric-Furlan S, Wormser GP: Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York state and Borrelia afzelii in Slovenia. Ann Intern Med 1999;130:32-36.
16. Steere AC: Ly me disease. N Engl J Med 1989;321:586-596.
17. Asbrink E, Hovmark A: Early and late cutaneous manifestations in Ixodes -borne borreliosis (erythema migrans borreliosis, Lyme borreliosis). Ann NY Acad Sci 1988;539:4-15.
18. Steere AC: Lyme disease. N Engl J Med 2001;345:115-125.
19. Weber K, Neubert U, Buchner SA: Erythema migrans and early signs and symptoms; in Weber K, Burgdorfer W (eds): Aspects of Lyme Borreliosis. Heidelberg, Springer, 1993, pp 105-121.
20. Masters E, Granter S, Duray P, Cordes P: Physiciandiagnosed erythema migrans and erythema migrans-like rashes following Lone Star tick bites. Arch Dermatol 1998;134:955-960.
21. Masters EJ, Grigery CN, Masters BE: STARI, or Masters Disease: Lone star tick-vectored Lyme-like illness. Infect Dis Clin North Am 2008;22:361-376.
22. Krause PJ, Telford SR 3rd, Spielman A, Sikand V, Ryan R, Christianson D, Burke G, Brassard P, Pollack R, Peck J, Persing DH: Concurrent Lyme disease and babesiosis: evidence for increased severity and duration of illness. JAMA 1996;275:1657-1660.
23. Cimperman J, Maraspin V, Lotric-Furlan S, Avsic-Zupanc T, Picken RN, Strle F: Concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in patients with acute meningitis or meningoencepha litis. Infection 1998;26:160-164.
24. Nadelman RB, Horowitz HW, Hsieh TC, Wu JM, Aguero-Rosenfeld ME, Schwartz I, Nowakowski J, Varde S, Wormser GP: Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 1997;337:27-30.
25. Herxheimer K, Hartmann K: Über Acrodermatitis chronica atrophicans. Arch Dermatol Syph 1902;61:57-76.
26. Afzelius A: Verhandlungen der Dermatologischen Gesellschaft zu Stockholm, 28 Oct 1909. Arch Dermatol Syph 1910;101:404.
27. Lipschütz B: Über eine seltene Erythemform (Erythema chronicum migrans). Arch Dermatol Syph 1913;118:349-356.
28. Dandache P, Nadelma n RB: Ery t hema mig ra ns. Infect Dis Clin North Am 2008;22:235-260.
29. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, Elmrud H, Carlsson M, Runehagen A, Svanborg C, Norrby R: An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995;333:1319-1327.
30. Anonymous: Epidemiologic Surveillance of Infectious Diseases in Slovenia (in Slovene). Ljubljana, Institute of Public Health of the Republic of Slovenia, Slovenia, 2000.
31. Anonymous: Epidemiologic Surveillance of Infectious Diseases in Slovenia (in Slovene). Ljubljana, Institute of Public Health of the Republic of Slovenia, 2008.
32. Ornstein K, Berglund J, Nilsson I, Norrby R, Bergstrom S: Characterization of Lyme borreliosis isolates from patients with erythema migrans and neuroborreliosis in southern Sweden. J Clin Microbiol 2001;39:1294-1298.
33. Carlsson SA, Granlund H, Jansson C, Nyman D, Wahlberg P: Characteristics of erythema migrans in Borrelia afzelii and Borrelia garinii infections. Scand J Infect Dis 2003;35:31-33.
34. Cerar T, Ružić-Sabljić E, Glinsek U, Zore A, Strle F: Comparison of PCR methods and culture for the detection of Borrelia spp. in patients with erythema migrans. Clin Microbiol Infect 2008;14:653-658.
35. Zore A, Ružić-Sabljić E, Maraspin V, Cimperman J, Lotrič-Furlan S, Pikelj A, Jurca T, Logar M, Strle F: Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema mi-grans. Wien Klin Wochenschr 2002;114:606-609.
36. Kuiper H, Cairo I, van Dam A, de Jongh B, Ramselaar T, Spanjaard L, Dankert J: Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients. Br J Dermatol 1994;130:466-472.
37. Ciceroni L, Ciarrochi S, Ciervo A, Mondarini V, Guzzo F, Caruso G, Murgia R, Cinco M: Isolation and characterization of Borrelia burgdorferi sensu lato strains in an area of Italy where Lyme borreliosis is endemic. J Clin Microbiol 2001;39:2254-2260.
38. Ružić-Sabljić E, Maraspin V, Lotrič-Furlan S, Jurca T, Logar M, Pikelj-Pečnik A, Strle F: Characterization of Borrelia burgdorferi sensu lato strains isolated from human material in Slovenia. Wien Klin Wochenschr 2002;114:544-550.
39. Fingerle V, Schulte-Spechtel UC, Ružić-Sabljić E, Leonhard S, Hofmannd H, Weber K, Pfister K, Strle F, Wilske B: Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol 2008;298:279-290.
40. Picken RN, Cheng Y, Strle F, Picken MM: Patient isolates of Borrelia burgdorferi sensu lato with genotypic and phenotypic similarities of strain 25015. J Infect Dis 1996;174:1112-1115.
41. Strle F, Picken RN, Cheng Y, Cimperman J, Maraspin V, Lotrič-Furlan S, Ružić-Sabljić E, Picken MM: Clinical findings for patients with Lyme borreliosis caused by Borrelia burgdorferi sensu lato with genotypic and phenotypic similarities to strain 25015. Clin Infect Dis 1997;25:273-280.
42. Foldvari G, Farkas R, Lakos A: Borrelia spielmanii erythema migrans, Hungary. Emerg Infect Dis 2005;11:1794-1795.
43. Maraspin V, Ružić-Sabljić E, Strle F: Lyme borreliosis and Borrelia spielmanii. Emerg Infect Dis 2006;12:1177.
44. Ružić-Sabljić E, Zore A, Strle F: Characterization of Borrelia burgdorferiW sensu lato isolates by pulsedfield gel electrophoresis after MluI restriction of genomic DNA. Research Microbiol 2008;159:441-448.
45. Oksi J, Marttila H, Soini H, Aho H, Uksila J, Viljanen MK: Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans. APMIS 2001;109:581-588.
46. Picken RN, Cheng Y, Strle F, Cimperman J, Maraspin V, Lotrič-Furlan S, Ružić-Sabljić E, Han D, Nelson JA, Picken MM, Trenholme GT: Molecular characterization of Borrelia burgdorferi sensu lato from Slovenia revealing significant differences between tick and human isolates. Eur J Clin Microbiol Infect Dis 1996;15:313-323.
47. Picken MM, Picken RN, Han D, Cheng Y, Strle F: Single-tube nested polymerase chain reaction assay based on flagellin gene sequences for detection of Borrelia burgdorferi sensu lato. Eur J Clin Microbiol Infect Dis 1996;6:489-498.
48. Seinost G, Golde WT, Berger BW, Dunn JJ, Qiu D, Dunkin DS, Dykhuizen DE, Luft BJ, Dattwyler RJ: Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease. Arch Dermatol 1999;135:1329-1333.
49. Ružić-Sabljić E, Arnez M, Lotrič-Furlan S, Maraspin V, Cimperman J, Strle F: Genotypic and phenotypic characterisation of Borrelia burgdorferi sensu lato strains isolated from human blood. J Med Microbiol 2001;50:896-901.
50. Ružić-Sabljić E, Arnez M, Logar M, Maraspin V, Lotrič-Furlan S, Cimperman J, Strle F: Comparison of Borrelia burgdorferi sensu lato strains isolated from specimens obtained simultaneously from two different sites of infection in individual patients. J Clin Microbiol 2005;43:2194-2200.
51. Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, Aguero-Rosenfeld M, Wormser GP: The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 1996;100:502-508.
52. Smith R P, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, Holman MS, Persing DH, Steere AC: Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 2002;136:421-428.
53. Weber K, Neubert U: Clinical features of early erythema migrans disease and related disorders. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986;263:209-228.
54. Asbrink E, Olsson I, Hovmark A: Erythema chronicum migrans Afzelius in Sweden: a study on 231 patients. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986;263:229-236.
55. Strle F, Nelson JA, Ružić-Sabljić E, Nowakowski J, Picken R N, S chwa r t z I, Ma r aspin V, Ag uero -Ro senfeld ME, Varde S, Lotrič-Furlan S, Wormser GP: European Lyme borreliosis:231 culture-confirmed cases involving patients with erythema migrans. Clin Infect Dis 1996;23:61-65.
56. Strle F, Videcnik J, Zorman P, Cimpe rman J, LotričFurlan S, Maraspin V: Clinical and epidemiological findings for patients with erythema migrans: comparison of cohorts from the years 1993 and 2000. Wien Klin Wochenschr 2002;114:493-497.
57. De Koning J, Duray PH: Histopathology of human Lyme borreliosis; in Weber K, Burgdorfer W (eds): Aspects of Lyme Borreliosis. Heidelberg, Springer, 1993, pp 70-92.
58. Mullegger RR, Means TK, Shin JJ, Lee M, Jones KL, Glickstein LJ, Luster AD, Steere AC: Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in ly mphocy toma. Infect Immun 2007;75:4621-4628.
59. Maraspin V, Ružić-Sabljić E, Cimperman J, LotričFurlan S, Jurca T, Picken RN, Strle F: Isolation of Borrelia burgdorferi sensu lato from blood of patients with erythema migrans. Infection 2001;29:65-70.
60. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, Sigal LH, Spieler PN, Stenn KS, Malawista SE: The early clinical manifestations of Lyme disease. Ann Intern Med 1983;99:76-82.
61. Logar M, Ružić-Sabljić E, Maraspin V, Lotrič-Furlan S, Cimperman J, Jurca T, Strle F: Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii. Infection2003;31:404-409.
62. Bennet L, Fraenkel CJ, Garpmo U, Halling A, Ingman M, Ornstein K, Stjernberg L, Berglund J: Clinical appearance of erythema migrans caused by Borrelia afzelii and Borrelia garinii - ef fect of t he patient's sex. Wien Klin Wochenschr 206;118:531-537.
63. Arnez M, Ružić-Sabljić E, Ahcan J, Radsel-Medvescek A, Pleterski-Rigler D, Strle F: Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans. Pediatr Infect Dis J 2001;20:251-255.
64. Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D, Byrne DW, Nowakowski J: Hematogenous dissemination in early Lyme disease. Ann Intern Med 2005;142:751-755.
65. Arnez M, Pleterski-Rigler D, Ahcan J, Ružić-Sabljić E, Strle F: Demographic features, clinical characteristics and laboratory findings in children with multiple erythema migrans in Slovenia. Wien Klin Wochensc hr 2001;113:98-101.
66. Arnez M, Pleterski-Rigler D, Luznik-Bufon T, Ružić- Sabljić E, Strle F: Children with multiple erythema migrans: are there any pre-treatment symptoms and/or signs suggestive for central nervous system involvement? Wien Klin Wochenschr 2002;114:524-529.
67. Mullegger RR: Dermatological manifestations of Lyme borreliosis. Eur J Dermatol 2004;14:296-309.
68. Asbrink E, Hovmark A, Olsson I: Lymphadenosis benigna cutis solitaria - borrelia lymphocytoma in Sweden. Zentralbl Bakteriol 1989;(suppl 18):156-163.
69. Strle F, Pleterski-Rigler D, Stanek G, Pejovnik-Pustinek A, Ruzic E, Cimperman J: Solitary borrelial lymphocytoma: report of 36 cases. Infection 1992;20:201-206.
70. Strle F, Maraspin V, Pleterski-Rigler D, Lotrič-Furlan S, Ružić-Sabljić E, Jurca T, Cimperman J: Treatment of borrelial lymphocytoma. Infection 1996;24:80-84.
71. Maraspin V, Cimperman J, Lotrič-Furlan S, Ružić Sabljić E, Jurca T, Picken RN, Strle F: Solitary borrelial lymphocytoma in adult patients. Wien Klin Wochenschr 2002;114:515-523.
72. Hovmark A, Asbrink E, Weber K, Kaudewitz P: Borrelial lymphocytoma; in Weber K, Burgdorfer W (eds): Aspects of Lyme Borreliosis. Heidelberg, Springer, 1993, pp 122-130.
73. Colli C, Leinweber B, Mullegger R, Chott A, Kerl H, Cerroni L: Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol 2004;31:232-240.
74. Strle F: Lyme borreliosis in Slovenia. Zentralbl Bakteriol 1999;289:643-652.
75. Picken RN, Strle F, Ružić-Sabljić E, Maraspin V, Lotrič-Furlan S, Cimperman J, Cheng Y, Picken MM: Molecular subtyping of Borrelia burgdorferi sensu lato isolates from five patients with solitary lymphcytoma. J Invest Dermatol 1997;108:92-97.
76. Busch U, Hizo-Teufel C, Bohmer R, Fingerle V, Rossler D, Wilske B, Preac-Mursic V: Borrelia burgdorferi sensu lato strains isolated from cutaneous Lyme borreliosis biopsies differentiated by pulsed field gel electrophoresis. Scand J Infect Dis 1996;28:583-589.
77. Ružić-Sabljić E, Strle F, Cimperman J, Maraspin V, Lotrič-Furlan S, Pleterski-Rigler D: Characterisation of Borrelia burgdorferi sensu lato strains isolated from patients with skin manifestations of Lyme borreliosis residing in Slovenia. J Med Microbiol 2000;49:47-53.
78. Weber K, Schierz G, Wilske B, Preac-Mursic V: Das Lymphozytom - eine Borrelize? Z Hautkr 1985;60:1585-1598.
79. Weber K, Neubert U, Thurmayr R: Antibiotic therapy in early erythema migrans disease and related disorders. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986;263:377-388.
80. Hovmark A, Asbrink E, Olsson I: The spirochetal etiology of lymphadenosis benigna cutis solitaria. Acta Derm Venereol 1986;66:479-484.
81. Asbrink E, Hovmark A: Cutaneous manifestations in Ixodes-borne borrelia spirechetosis. Int J Dermatol 1987;26:215-225.
82. Boye T: What k ind of clinical, epidemiologica l, and biological data is essential for the diagnosis of Lyme borreliosis? Dermatological and ophtalmological courses of Lyme borreliosis. Med Mal Infect 2007;37(suppl 3):S175-S188.
83. Lipsker D: Dermatological aspects of Lyme borreliosis. Med Mal Infect 2007;37:540-547.
84. DiCaudo DJ, Su WP, Marshall WF, Malawista SE, Barthold S, Persing DH: Acrodermatitis chronica atrophicans in the United States: clinical and histopathologic features of six cases. Cutis 1994;54:81-84.
85. Lavoie PE, Wilson AJ, Tuffanelli DL: Acrodermatitis chronica atrophicans with antecedent Lyme disease in a California. Case report. Mol Pathol 1997;50:186-193.
86. Wienecke R, Zochl ing N, Neuber t U, Schlupen EM, Meurer M, Volkenandt M: Molecular subtyping of in erythema migrans and acrodermatitis chronica atrophicans. J Invest Dermatol 1994;103:19-22.
87. Ohlenbusch A, Matuschka FR, Richter D, Christen HJ, Thomssen R, Spielman A, Eiffert H: Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis 1996;174:421-423.
88. Rijpkema SG, Tazelaar DJ, Molkenboer MJ, Noordhoek GT, Plantinga G, Schouls L, Schellekens JF: Detection of Borrelia afzelii, Borrelia burgdorferi sensu stricto, Borrelia garinii and group VS116 by PCR in skin biopsies of patients with erythema migrans and acrodermatitis chronica atrophicans. Clin Microbiol Infect 1997;3:109-116.
89. Lunemann JD, Zarmas S, Priem S, Franz J, Zschenderlein R, Aberer E, Klein R, Schouls L, Burmester GR, Krause A: Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme bor-reliosis. J Clin Microbiol 2001;39:1130-1133.
90. Maraspin V, Ružić-Sabljić E, Strle F: Isolation of Borrelia burgdorferi sensu lato from a fibrous nodule in a patient with acrodermatitis chronica atrophicans. Wien K lin Wochenschr 2002;114:533-534.
91. Picken RN, Strle F, Picken MM, Ružić-Sabljić E, Maraspin V, Lotric-Furlan S, Cimperman J: Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions. J Invest Dermatol 1998;110:211-214.
92. Asbrink E: Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans: early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes. Acta Derm Venereol Suppl (Stockh) 1985;118:1-63.
93. Asbrink E, Brehmer Andersson E, Hovmark A: Acrodermatitis chronica atrophicans - a spirochetosis: clinical and histopathological picture based on 32 patients. Am J Dermatopathol 1986;8:209-219.
94. Brehmer-Andersson E, Hovmark A, Asbrink E: Acrodermatitis chronica atrophicans: histopathologic findings and clinical correlations in 111 cases. Acta Derm Venereol 1998;78:207-213.
95. Asbrink E, Hovmark A, Olsson I: Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986;263:253-261.
96. Asbrink E, Hovmark A, Weber K: Acrodermatitis chronica atrophicans; in Weber K, Burgdorfer W (eds): Aspects of Lyme Borreliosis. Heidelberg, Springer, 1993, pp 193-204.
97. Hopf HC: Peripheral neuropathy in acrodermati tis chronica atrophicans (Herxheimer). J Neurol Neurosurg Psychiat 1975;38:452-458.
98. Kristoferitsch W, Sluga E, Graf M, Partsch H, Neumann R, Stanek G, Budka H: Neuropathy associated with acrodermatitis chronica atrophicans: clinical and morphological features. Ann NY Acad Sci 1988;539:35-45.
99. Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E: Peripheral neuropathy in acrodermatitis chronica atrophicans - effect of treatment. Acta Neurol Scand 2002;106:253-257.
100. Herzer P: Joint manifestations; in Weber K, Burgdorfer W (eds): Aspects of Lyme Borreliosis. Heidelberg, Springer, 1993, pp 168-184.
101. Hauser W: Zur Kenntnis der Acrodermatitis chronica atrophicans. Arch Dermatol Syph 1955;199;350-393.
102. Hoesly JM, Mertz LE, Winkelmann RK: Localized scleroderma (morphea) and antibody to Borrelia burgdorferi. J Am Acad Dermatol 1987;17:455-458.
103. Akimoto S, Ishikawa O, Miyachi Y: The absence of antibodies against Borrelia burgdorferi in the sera of Japanese patients with localized scleroderma. J Rheumatol 1996;3:573-574.
104. Breier F, Klade H, Stanek G, Poitschek C, Kirnbauer R, Dorda W, Aberer E: Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma. Br J Dermatol 1996;134:285-291.
105. Buechner SA, Lautenschlager S, Itin P, Bircher A, Erb P: Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Arch Dermatol 1995;131:673-677.
106. Fujiwara H, Fujiwara K, Hashimoto K, Mehregan AH, Schaumburg-Lever G, Lange R, Schempp C, Gollnick H: Detection of Borrelia burgdorferi DNA (B. garinii or B. afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol 1997;133:41-44.
107. Dillon WI, Saed GM, Fivenson DP: Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et at rophicus of patients from North America. J Am Acad Dermatol 1995;33:617-620.
108. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP: Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005;18:484-509.
109. Aberer E, Stanek G, Ertl M, Neu mann R: Evidence for spirochetal origin of circumscribed scleroderma (morphea). Acta Derm Venereol 1987;67:225-231.
110. Weber K, Preac-Mursic V, Reimers CD: Spirochetes isolated from two patients with morphea. Infection 1988;16:25-26.
111. Breier FH, Aberer E, Stanek G, Khanakaha G, Schlick A, Tappeiner G: Isolation of Borrelia afzelii from circumscribed scleroderma. Br J Dermatol 1999;140:925-930.
112. Ranguin G, Boisnic S, Souteyrand P, Baranton G, Piette JC, Godeau P, Francès C: No evidence for a spirochetal origin of localized scleroderma. Br J Dermatol 1992;127:218-220.
113. Alonso-Llamazares J, Persing DH, Anda P, Gibson LE, Rutledge BJ, Iglesias L: No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain: a prospective study and literature review. Acta Derm Venereol 1997;77:299-304.
114. Breier F, Khanakah G, Stanek G, Kunz G, Aberer E, Schmidt B, Tappeiner G: Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus. Br J Dermatol 2001;144:387-392.
115. Cerroni L, Zöchling N, Pütz B, Kerl H: Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997;24:457-461.
116. Kutting B, Bonsmann G, Metze D, Luger TA, Cerroni L: Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol 1997;36:311-314.
117. Schöllkopf C, Melbye M, Munksgaard L, Ekström Smedby K, Rostgaard K, Glimelius B, Chang ET, Roos G, Hansen M, Adami HO, Hjalgrim H: Borrelia infection and risk of non-Hodgkin lymphoma. Blood 2008;111:5524-5529.
118. Wood GS, Kamath NV, Guitart J, Heald P, Kohler S, Smoller BR, Cerroni L: Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol 2001;28:502-507.
119. Munksgaard L, Frisch M, Melbye M, Hjalgrim H: Incidence patterns of Lyme disease and cutaneous B-cell non-Hodgkin's lymphoma in the United States. Dermatology 2000;201:351-352.
120. Goodlad JR, Davidson MM, Hollowood K, Ling C, MacKenzie C, Christie I, Batstone PJ, Ho-Yen DO: Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the highlands of Scotland. Am J Surg Pathol 2000;24:1279-1285.
121. Li C, Inagaki H, Kuo TT, Hu S, Okabe M, Eimoto T: Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 Asian cases. Am J Surg Pathol 2003;27:1061-1069.
122. Senff NJ, Noordijk EM, Youn H, Kim YH, Bagot M, Berti E, Cerroni L, Dummer R, Duvic M, Hoppe RT, Pimpinelli N, Rosen ST, Vermeer MH, Whittaker S, Willemze R: European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood 2008;112:1600-1609.
123. Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M: Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection: MALT Lymphoma Study Group. Lancet 1995;345:1591-1594.
124. Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer A, Wundisch T, Ehninger G, Stolte M, Bayerdorffer E: Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997;89:1350-1355.
125. Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F: Eradication of Helicobacter pylori infection in primary lowgrade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-769.
126. Dreno B: Standard and new treatments in cutaneous B-cell lymphomas. J Cutan Pathol 2006;33(suppl 1):S47-S51.
127. Zenahlik P, Fink-Puches R, Kapp KS, Kerl H, Cerroni L: Therapy of primary cutaneous B-cell lymphomas. Hautarzt 2000;51:19-24.
128. Hoefnagel JJ, Vermeer MH, Jansen PM, Heule F, van Voorst Vader PC, Sanders CJ, Gerritsen MJ, Geerts ML, Meijer CJ, Noordijk EM, Willemze R: Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases. Arch Dermatol 2005;141:1139-1145.
129. Bogle MA, Riddle CC, Triana EM, Jones D, Duvic M: Primary cutaneous B-cell lymphoma. J Am Acad Dermatol 2005;53:479-484.
130. Monari P, Farisoglio C, Calzavara Pinton PG: Borrelia burgdorferi -associated primary cutaneous marginal-zone B-cell lymphoma: a case report. Dermatology 2007;215:229-232.
131. Roggero E, Zucca E, Mainetti C, Bertoni F, Valsangiacomo C, Pedrinis E, Borisch B, Piffaretti JC, Cavalli F, Isaacson PG: Eradication of Borrelia burgdorferi infection in primary marginal zone Bcell lymphoma of the skin. Hum Pathol 2000;31:263-268.
132. Ryffel K, Peter O, Rutti B, Suard A, Dayer E: Scored antibody reactivity determined by immunoblotting shows an association between clinical manifestations and presence of Borrelia burgdorferi sensu st ricto, B. garinii, B. afzelii, and B. val aisiana in humans. J Clin Microbiol 1999;37:4086-4092.
133. Peter O, Bretz AG, Postic D, Dayer E: Association of distinct species of Borrelia burgdorferi sensu lato with neuroborreliosis in Switzerland. Clin Microbiol Infect 1997;3:423-431.
134. Hizo-Teufel C, Fingerle V, Nitschko H, Wilske B, Preac-Mursic V: Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. afzelii and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR. J Clin Microbiol 1996;34:1072-1078.
135. Ružić-Sabljić E, Lotrič-Furlan S, Maraspin V, Cimperman J, Pleterski-Rigler D, Strle F: Analysis of Borrelia burgdorferi sensu lato isolated from cerebrospinal f luid. APMIS 2001;109:707-713.
136. Strle F, Ružić-Sabljić E, Cimperman J, Lotricč-Furlan S, Maraspin V: Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 2006;43:704-710.
137. Lebech AM, Hansen K, Rutledge BJ, Kolbert CP, Rys PN, Pershing DH: Diagnostic detection and direct genotyping of Borrelia burgdorferi by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. Mol Diagn 1998;3:131-141.
138. Ornstein K, Berglund J, Bergstrom S, Norrby R, Barbour AG: Three major Lyme Borrelia genospecies (Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii) identified by PCR in cerebrospinal fluid from patients with neuroborreliosis in Sweden. Scand J Infect Dis 2002;34:341-346.
139. Steere AC, Schoen RT, Taylor E: The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107:725-731.
140. Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE: Neurologic abnormalities of Lyme disease. Medicine 1979;58:281-294.
141. Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL: Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996;335:1270-1274.
142. Centers for Disease Control and Prevention: Lyme disease - United States, 2003-2005. MMWR 2007;6:573-576.
143. Clark JR, Carlson RD, Sasaki CT, Pachies AR, Steere AC: Facial paralysis in Lyme disease. Laryngoscope 1985;95:1341-1345.
144. Shapiro ED, Gerber MA: Lyme disease and facial nerve palsy. Arch Pediatr Adolesc Med 1997;151:1183-1184.
145. Halperin JJ, Golightly M: Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group. Neurology 1992;42:1268-1270.
146. Halperin JJ: Nervous system Lyme disease. Infect Dis Clin North Am 2008;22:261-274.
147. Lotrič-Furlan S, Cimperman J, Maraspin V, Ružić- Sabljić E, Logar M, Jurca T, Strle F: Lyme borreliosis and peripheral facial palsy. Wien Klin Wochenschr 1999;111:970-975.
148. Pfister HW, Kristoferitsch W, Meier C: Early neurological involvement (Bannwarth's syndrome); in Weber K, Burgdorfer W (eds): Aspects of Lyme Borreliosis. Heidelberg, Springer, 1993, pp 152-167.
149. Kristoferitsch W: Neuropathien bei Lyme-Borreliose. Wien, Springer, 1989.
150. Stiernstedt GT, Granstrom M, Hederstedt B, Skoldenberg B: Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol 1985;21:819-825.
151. Pfister HW, Einhaupl KM, Wilske B, Preac-Mursic V: Bannwarth's syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis. Zentra lbl Ba kteriol Mikrobiol Hyg [A] 1987;263:343-347.
152. Bammer H, Schenk K: Meningomyeloradikulitis nach Zeckenbiss mit Erythem. Dtsch Z Nervenheilkunde 1965;187:25-34.
153. Schaltenbrand G: Durch Arthropoden übertragene Infektionen der Haut und des Nervensystems. Verh Dtsch Ges Inn Med 1967;72:975-1005.
154. Erbsloh F, Kohlmeyer K: Über polytope Erkrankungen des peripheren Nervensystems bei Lymphozytarer Meningitis. Fortschr Neurol Psychiat r 1968;36:321-342.
155. Horstup P, Ackermann R: Durch Zecken übertragene Meningopolyneuritis (Garin-Bujadoux-Bannwarth). Fortschr Neurol Psychiatr 1973;41:583-606.
156. Kristoferitsch W, Spiel G, Wessely P: Meningopolyneuritis (Garin-Bujadoux-Bannwarth): clinical aspects and laboratory findings. Nervenarzt 1983;54:640-646.
157. Pachner AR, Steere AC: The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985;111:47-53.
158. Duray PH: Clinical pathologic correlations of Lyme disease. Rev Infect Dis 1989;11(suppl 6): S1487-S1493.
159. Meurers B, Kohlhepp W, Gold R, Rohrbach E, Mertens HG: Histopathological findings in the central and peripheral nervous systems in neuroborreliosis: a report of three cases. J Neurol 1990;237:113-116.
160. Roberts ED, Bohm RP Jr, Lowrie RC Jr, Habicht G, Katona L, Piesman J, Philipp MT: Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 1998;178:722-732.
161. Garin C, Bujadoux R: Paralisie par les tiques. J Med Lyon 1922;71:765-767.
162. Kristoferitsch W: Neurological manifestations of Lyme borreliosis: clinical definition and differential diagnosis. Scand J Infect Dis 1991;77 (suppl):64-73.
163. Hansen K: Lyme neuroborreliosis: improvements of the laboratory diagnosis and a survey of epidemiological and clinical features in Denmark 1985-1990. Acta Neurol Scand 1994;89(suppl 151):7-44.
164. Pfadenhauer K, Schonsteiner T, Stohr M: Thoracoabdominal manifestation of stage II Lyme neuroborreliosis. Ner venarzt 1998;69:296-299.
165. Bagger-Sjoback D, Remahl S, Ericsson M: Longterm outcome of facial palsy in neuroborreliosis. Otol Neurotol 2005;26:790-795.
166. Skogman BH, Croner S, Odkvist L: Acute facial palsy in children - a 2-year follow-up study with focus on Lyme neuroborreliosis. Int J Pediatr Otorhinolaryngol 2003;67:597-602.
167. Sibony P, Halperin J, Coyle PK, Patel K: Reactive Lyme serology in optic neuritis. J Neuroophthalmol 2005;25:71-82.
168. Steenhoff AP, Smith MJ, Shah SS, Coffin SE: Neuroborreliosis with progression from pseudotumor cerebri to aseptic meningitis. Pediatr Infect Dis J 2006;25:91-92.
169. Feder HM Jr: Lyme disease in children. Infect Dis Clin North Am 2008;22:315-326.
170. Kristoferitsch W. Chronic peripheral neuropathy; in Weber K, Burgdorfer W (eds): Aspects of Lyme Borreliosis. Heidelberg, Springer, 1993, pp 219-227.
171. Logigian EL, Kaplan RF, Steere AC: Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323:1438-1444.
172. Cerar T, Ogrinc K, Cimperman J, Lotrič-Furlan S, Strle F, Ružić-Sabljić E: Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 2008;46:3375-3379.
173. Fish AE, Pride YB, Pinto DS: Lyme carditis. Infect Dis Clin North Am 2008;22:275-288.
174. Steere AC, Batsford WP, Weinberg M, Alexander J, Berger , Wolfson S, Malawista SE: Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 1980;93:8-16.
175. Van der Linde MR: Lyme carditis; in Weber K, Burgdorfer W (eds): Aspects of Lyme Borreliosis. Heidelberg, Springer, 1993, pp 131-151.
176. Sigal LH: Early disseminated Lyme disease: cardiac manifestations. Am J Med 1995;98(suppl 4A):25-28.
177. Rubin DA, Sorbera C, Nikitin P, McAllister A, Wormser GP, Nadelman RB: Prospective evaluation of heart block complicating early Lyme disease. Pacing Clin Electrophysiol 1992;15:252-255.
178. Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, Nowakowski J, Schmid CH, Laukamp S, Buscarino C, Krause DS: Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 1998;339:209-215.
179. Sigal LH, Zahradnik JM, Lavin P, Patella SJ, Bryant G, Haselby R, Hilton E, Kunkel M, Adler-Klein D, Doherty T, Evans J, Molloy PJ, Seidner AL, Sabetta JR, Simon HJ, Klempner MS, Mays J, Marks D, Malawista SE: A vaccine consisting of recombinant Borrelia burgdorferi outer-surface A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med 1998;339:216-222.
180. Stanek G, Klein J, Bittner R, Glogar D: Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med 1990;322:249-252.
181. Marcus LC, Steere AC, Duray PH, Anderson AE, Mahoney EB: Fatal pancarditis in a patient with coexisting Lyme disease and babesiosis. Ann Intern Med 1985;103:374-376.
182. Reznick JW, Braunstein DB, Walsh RL, Smith CR, Wolfson PM, Gierke LW, Gorelkin L, Chandler FW: Lyme carditis: electrophysiologic and histopathologic study. Am J Med 1986;81:923-927.
183. Cox J, Krajden M: Cardiovascular manifestations of Lyme disease. Am Heart J 1991;122:1449-1455.
184. de Koning J, Hoogkamp-Korstanje JA, van der Linde MR, Crijns HJ: Demonstration of spirochetes in cardiac biopsies of patients with Lyme disease. J Infect Dis 1989;160:150-153.
185. van der Linde MR: Lyme carditis: clinical characteristics of 105 cases. Scand J Infect Dis 1991;77(suppl):81-84.
186. McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S: Lyme carditis: an important course of reversible heart block. Ann Intern Med 1989;110:339-345.
187. Pinto DS: Cardiac manifestations of Lyme disease. Med Clin North Am 2002;86:285-296.
188. Cary NR, Fox B, Wright DJ, Cutler SJ, Shapiro LM, Grace AA: Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node. Postgrad Med J 1990;66:134-136.
189. Midttun M, Lebech AM, Hansen K, Videbaek J: Lyme carditis: a clinical presentation and long time follow-up. Scand J Infect Dis 1997;29:153-157.
190. Lardieri G, Salvi A, Camerini F, Cinco M, Trevisan G: Isolation of Borrelia burgdorferi from myocardium. Lancet 1993;342:490.
191. Gasser R, Dusleag J, Reisinger E, Stauber E, Feigl B, Pongratz S, Klein W, Furian C, Pierer K: Reversal by ceftriaxone of dilated cardiomyopathy Borrelia burgdorferi infection. Lancet 1992;339:1174-1175.
192. Sonnesyn SW, Diehl SC, Johnson RC, Kubo SH, Goodman JL: A prospective study of the seroprevalence of Borrelia burgdorferi infection in patients with severe heart failure. Am J Cardiol 1995;76:97-100.
193. Sangha O, Phillips CB, Fleischman KE, Wang TJ, Fossel AH, Lew R, Liang MH, Shadick NA: Lack of cardiac manifestations among patients with previously treated Lyme disease. Ann Intern Med 1998;128:346-353.
194. Steere AC, Schoen RT, Taylor E: The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107:725-731.
195. Krause PJ, McKay K, Thompson CA, Sikand VK, Lentz R, Lepore T, Closter L, Christianson D, Telford SR, Persing D, Radolf JD, Spielman A; Deer-Associated Infection Study Group: Disease-specific diagnosis of coinfecting tick-borne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis 2002;34:1184-1191.
196. Gans O, L andes E: A krodermatitis atrophicans arthropathica. Hautarzt 1952;3:151-155.
197. Weber K: Erythema-chronicum migrans-Meningitis - eine bakterielle Infektionskrankheit? Münch Med Wochenschr 1974;116:1993-1998.
198. Bannwarth A: Chronische Lymphocytare Meningitis, entzündliche Polyneuritis und 'Rheumathis-mus'. Ein Beitrag zum Problem 'Allergie und Nervensystem' in zwei Teilen. Arch Psychiatr Nervenkr 1941;113:284-376.
199. Schaltenbrand G: Chronische aseptische Meningitis. Nervenarzt 1949;20:433-442.
200. Priem S, Munkelt K, Franz JK, Schneider U, Werner T, Burmester GR, Krause A: Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nationwide survey. Z Rheumatol 2003;62:450-458.
201. van der Heijden IM, Wilbrink B, Rijpkema SG, Schouls LM, Heymans PH, van Embden JD, Breedveld FC, Tak PP: Detection of Borrelia burgdorferi sensu stricto by reverse line blot in the joints of Dutch patients with Lyme arthritis. Arthritis Rheum 1999;42:1473-1480.
202. Jaulhac B, Heller R, Limbach FX, Hansmann Y, Lipsker D, Monteil H, Sibilia J, Piemont Y: Direct molecu lar ty ping of Borrelia burgdorferi sensu lato species in synovial samples from patients with Lyme arthritis. J Clin Microbiol 2000;38:1895-1900.
203. Limbach FX, Jaulhac B, Puechal X, Monteil H, Kuntz JL, Piemont Y, Sibilia J: Treatment resistant Lyme arthritis caused by Borrelia garinii. Ann R heum Dis 2001;60:284-286.
204. Vasiliu V, Herzer P, Rossler D, Lehnert G, Wilske B: Heterogeneity of Borrelia burgdorferi sensu lato demonstrated by an ospA-type-specific PCR in synovial fluid from patients with Lyme arthritis. Med Microbiol Immunol 1998;187:97-102.
205. Eiffert H, Karsten A, Thomssen R, Christen HJ: Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis 1998;30:265-268.
206. Steere AC, Glickstein L: Elucidation of Lyme arthritis. Nat Rev Immunol 2004;4:143-152.
207. Puius YA, Kalish RA: Lyme arthritis: pathogenesis, clinical presentation, and management. Infect Dis Clin North Am 2008;22:289-300.
208. Guerau-de-Arellano M, Huber BT: Chemokines and Toll-like receptors in Lyme disease pathogenesis. Trends Mol Med 2005;11:114-120.
209. Coburn J, Fischer JR, Leong JM: Solving a sticky problem: new genetic approaches to host cell adhesion by the Lyme disease spirochete. Mol Microbiol 2005;57:1182-1195.
210. Hu LT, Eskildsen MA, Masgala C, Steere AC, Arner EC, Pratta MA, Grodzinsky AJ, Loening A, Perides G: Host metalloproteinases in Lyme arthritis. Arthritis Rheum 2001;44:1401-1410.
211. Behera AK, Hildebrand E, Scagliotti J, Steere AC, Hu LT: Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine Lyme arthritis. Infect Immun 2005;73:126-134.
212. Johnston YE, Duray PH, Steere AC, Kashgarian M, Buza J, Malawista SE, Askenase PW: Lyme arthritis: spirochetes found in synovial microangiopathic lesions. Am J Pathol 1985;118:26-34.
213. Duray PH, Steere AC: The spectrum of organ and systems pathology in human Lyme disease. Zentra lbl Bakteriol Mikrobiol Hyg [A] 1986;263:169-178.
214. Hollstrom E: Successful treatment of erythema chronicum migrans Afzelii. Acta Derm Venereol 1951;31:235-243.
215. Asbrink E, Olsson I: Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients: a comparison with Lyme disease. Acta Derm Venereol 1985;65:43-52.
216. Herzer P: Joint manifestations of Lyme borreliosis in Europe. Scand J Infect Dis 1991;77(suppl):55-63.
217. Kryger P, Hansen K, Vinterberg H, Pedersen FK: Lyme borreliosis among Danish patients with arthrit is. Scand J R heumatol 1990;19:77-81.
218. Valesova M, Trnavsky K: Joint manifestations of Lyme borreliosis in Czechoslovakian patients. Z Rheumatol 1990;49:192-196.
219. Rees DH, Axford JS: Lyme arthritis. Ann Rheum Dis 1994;53:553-556.
220. Steere AC, Hardin JA, Ruddy S, Mummaw JG, Malawista SE: Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum 1979;22:471-483.
221. Hardin JA, Steere AC, Malawista SE: Immune complexes and the evolution of Lyme arthritis: dissemination and localization of abnormal C1q binding activity. N Engl J Med 1979;301:1358-1363.
222. Lawson JP, Steere AC: Lyme arthritis: radiologic findings. Radiology 1985;154:37-43.
223. Snydman DR, Schenkein DP, Berardi VP, Lastavica CC, Pariser KM: Borrelia burgdorferi in joint fluid in chronic Lyme arthritis. Ann Intern Med 1986;104:798-800.
224. Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC: Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994;330:229-234.
225. Strle F: Ocular manifestations of Lyme borreliosis. Acta Dermatovenerol Alp Panoncia Adriat 1994;1-2:71-76.
226. Mikkila HO, Seppala IJ, Viljanen MK, Peltomaa MP, Karma A: The expanding clinical spectrum of ocular Lyme borreliosis. Ophthalmology 2000;107:581-587.
227. Karma A, Seppala I, Mikkila H, Kaakkola S, Viljanen M, Tarkkanen A: Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol 1995;119:127-135.
228. Mikkila H, Karma A, Viljanen M, Seppala I: The laboratory diagnosis of ocular Lyme borreliosis. Graefes Arch Clin Exp Ophthalmol 1999;237:225-230.
229. Colucciello M: Ocular Lyme borreliosis. N Engl J Med 2001;345:1350-1351.
230. Schonherr U, Strle F: Ocular manifestations; in Weber K, Burgdorfer W (eds): Aspects of Lyme Borreliosis. Heidelberg, Springer, 1993, pp 131-151.
231. Steere AC, Duray PH, Kauffmann DJ, Wormser GP: Unilateral blindness caused by infection with the Lyme disease spirochete , Borrelia burgdorferi. Ann Intern Med 1985;103:382-384.
232. Carvounis PE, Mehta AP, Geist CE: Orbital myo-sitis associated wit h Borrelia burgdorferi (Lyme disease) infection. Ophthalmology 2004;111:1023-1028.
233. Huppertz HI, Munchmeier D, Lieb W: Ocular manifestations in children and adolescents with Lyme arthritis. Br J Ophtha lmol 1999;83:1149-1152.
234. de Boer JH, Luyendijk L, Rothova A, Kijlstra A: Analysis of ocular fluids for local antibody production in uveitis. Br J Ophthalmol 1995;79:610-616.
235. Preac-Mursic V, Pfister HW, Spiegel H, Burk R, Wilske B, Reinhardt S, Bohmer R: First isolation of Borrelia burgdorferi from an iris biopsy. J Clin Neuroophthalmol 1993;13:155-161.
236. Lohmann CP, Winkler von Mohrenfels C, Gabler B, Reischl U, Kochanowski B: Polymerase chain reaction (PCR) for microbiological diagnosis in refractory infectious keratitis: a clinical study in 16 patients. Klin Monatsbl Augenheilkd 2000;217:37-42.
237. Stanek G, Konrad K, Jung M, Ehringer H: Shulman syndrome, a scleroderma subtype caused by Borrelia burgdorferi? Lancet 1987;1:1490.
238. Granter SR, Barnhill RL, Hewins ME, Duray PH: Identification of Borrelia burgdorferi in diffuse fasciitis with peripheral eosinophilia: borrelial fasciitis. JAMA 1994;272:1283-1285.
239. Hashimoto Y, Takahashi H, Matsuo S, Hirai K, Takemori N, Nakao M, Miyamoto K, Iizuka H: Polymerase chain reaction of Borrelia burgdorferi flagellin gene in Shulman syndrome. Dermatology 1996;192:136-139.
240. Muller-Felber W, Reimers CD, de Koning J, Fischer P, Pilz A, Pongratz DE: Myositis in Lyme borreliosis: an immunohistochemical study of seven patients. J Neurol Sci 1993;118:207-212.
241. Reimers CD, de Koning J, Neubert U, Preac-Mursic V, Koster JG, Muller-Felber W, Pongratz DE, Duray PH: Borrelia burgdorferi myositis: report of eight patients. J Neurol 1993;240:278-283.
242. Holmgren AR, Matteson EL: Lyme myositis. Art hritis R heum 2006;54:2697-2700.
243. Cadavid D, Bai Y, Dail D, Hurd M, Narayan K, Hodzic E, Barthold SW, Pachner AR: Infection and inflammation in skeletal muscle from nonhuman primates infected with different genospecies of the Lyme disease spirochete Borrelia burgdorferi. Infect Immun 2003;71:7087-7098.
244. Horowitz HW, Sanghera K, Goldberg N, Pechman D, Kamer R, Duray P, Weinstein A: Dermatomyositis associated with Lyme disease: case report and review of Lyme myositis. Clin Infect Dis 1994;18:166-171.
245. Waton J, Pinault AL, Pouaha J, Truchetet F: Lyme disease could mimic dermatomyositis. Rev Med Interne 2007;28:343-345.
246. Schnarr S, Wahl A, Jurgens-Saathoff B, Mengel M, Kreipe HH, Zeidler H: Nodular fasciitis, erythema migrans, and oligoarthritis: manifestations of Lyme borreliosis caused by Borrelia afzelii. Scand J Rheumatol 2002;31:184-186.
247. Kramer N, Rickert RR, Brodkin RH, Rosenstein ED: Septal panniculitis as a manifestation of Lyme disease. Am J Med 1986;81:149-152.
248. Hassler D, Zorn J, Zoller L, Neuss M, Weyand C, Goronzy J, Born IA, Preac-Mursic V: Nodular panniculitis: a manifestation of Lyme borreliosis? Hautarzt 1992;43:134-138.
249. Viljanen MK, Oksi J, Salomaa P, Skurnik M, Peltonen R, Kalimo H: Cultivation of Borrelia burgdorferi from the blood and a subcutaneous lesion of a patient with relapsing febrile nodular nonsuppurative panniculitis. J Infect Dis 1992;165:596-597.
250. Oksi J, Mertsola J, Reunanen M, Marjamaki M, Viljanen MK: Subacute multiple-site osteomyelitis caused by Borrelia burgdorferi. Clin Infect Dis 1994;19:891-896.
251. Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP; Ad Hoc International Lyme Disease Group, Agger WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Mead P, Morshed M, Porwancher R, Radolf JD, Smith RP Jr, Sood S, Weinstein A, Wong SJ, Zemel L: A critical appraisal of 'chronic Lyme disease'. N Engl J Med 2007;357:1422-1430.
252. Marques A: Chronic Lyme disease: a review. Infect Dis Clin North Am 2008;22:341-360.
253. Fraser DD, Kong LI, Miller FW: Molecular detection of persistent Borrelia burgdorferi in a man with dermatomyositis. Clin Exp Rheumatol 1992;10:387-390.
254. Sartin JS, Oettel KR: A morphealike skin condition caused by Borrelia burgdorferi in an immunocompromised patient. Mayo Clin Proc 2006;81:1259-1260.
255. Rodriguez M, Chou S, Fisher DC, De Girolami U, Amato AA, Marty FM: Lyme meningoradiculitis and myositis after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005;41:e112-e114.
256. Garcia-Monco JC, Frey HM, Villar BF, Golightly MG, Benach JL: Lyme disease concurrent with human immunodeficiency virus infection. Am J Med 1989;87:325-328.
257. Cordoliani F, Vignon-Pennamen MD, Assous MV, Vabres P, Dronne P, Rybojad M, Morel P: Atypical Lyme borreliosis in an HIV-infected man. Br J Dermatol 1997;137:437-439.
258. Dudle G, Opravil M, Luthy R, Weber R: Meningitis after acute Borrelia burgdorferi infection in HIV infection. Dtsch Med Wochenschr 1997;122:1178-1180.
259. Maraspin V, Lotrič-Furlan S, Cimperman J, Ružić- Sabljić E, Strle F: Erythema migrans in the immunocompromised host. Wien Klin Wochenschr 1999;111:923-932.
260. Furst B, Glatz M, Kerl H, Mullegger RR: The impact of immunosuppression on erythema migrans: a retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients. Clin Exp Dermatol 2006;31:509-514.
261. Maraspin V, Cimperman J, Lotrič-Furlan S, Logar M, Ružić-Sabljić E, Strle F: Erythema migrans in solid-organ transplant recipients. Clin Infect Dis 2006;42:1751-1754.
262. Millner M, Schimek MG, Spork D, Schnizer M, Stanek G: Lyme borreliosis in children: a controlled clinical study based on ELISA values. Eur J Pediatr 1989;148:527-530.
263. Barbour AG: Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984;57:521-525.
264. Preac-Mursic V, Wilske B, Reinhardt S: Culture of Borrelia burgdorferi on six solid media. Eur J Clin Microbiol Infect Dis 1991;10:1076-1079.
265. Marlovits S, Khanakah G, Striessnig G, Vécsei V, Stanek G: Emergence of Lyme arthritis after autologous chondrocyte transplantation. Arthritis Rheum 2004;50:259-264.
266. Aberer E, Bergmann AR, Derler AM, Schmidt B: Course of Borrelia burgdorferi DNA shedding in urine after treatment. Acta Derm Venereol 2007;87:39-42.
267. Rauter C, Mueller M, Diterich I, Zeller S, Hassler D, Meergans T, Hartung T: Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis. Clin Diagn Lab Immunol 2005;12:910-917.
268. Robertson J, Guy E, Andrews N, Wilske B, Anda P, Granström M, Hauser U, Moosmann Y, Sambri V, Schellekens J, Stanek G, Gray J: A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliosis. J Clin Microbiol 2000;38:2097-2102.
269. Hauser U, Lehnert G, Wilske B: Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreli-osis based on sera collected throughout Europe. J Clin Microbiol 1999;37:2241-2247.
270. Wilske B, Zöller L, Brade V, Eiffert H, Göbel UB, Stanek G: MiQ (Quality Standards for the Microbiological Diagnosis of Infectious Diseases) 12 2000: Lyme Borreliosis. Munich/Jena, Urban & Fischer Verlag, 2000.
271. Wilske B, Habermann C, Fingerle V, Hillenbrand B, Jauris-Heipke S, Lehnert G, Pradel I, Rössler D, Schulte-Spechtel U: An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis. Med Microbiol Immunol 1999;188:139-14 4.
272. Steere AC, McHugh G, Damle N, Sikand VK: Prospective study of serologic tests for Lyme disease. Clin Infect Dis 2008;47:188-195.
273. Cetin E, Sotoudeh M, Auer H, Stanek G: Paradigm Burgenland: risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates i n hunters. Wien K lin Wochenschr 2006;118:677-681.
274. Barbour AG, Jasinskas A, Kayala MA, Davies DH, Steere AC, Baldi P, Felgner PL: A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and whitefooted mice with Borrelia burgdorferi. Infect Immu n 2008;76:3374-3389.